Virological outcomes of various first-line ART regimens in patients harbouring HIV-1 E157Q integrase polymorphism: a multicentre retrospective study.
Shunsuke UnoHiroyuki GatanagaTsunefusa HayashidaMayumi ImahashiRumi MinamiMichiko KogaSei SamukawaDai WatanabeTeruhisa FujiiMasao TateyamaHideta NakamuraShuzo MatsushitaYusuke YoshinoTomoyuki EndoMasahide HoribaToshibumi TaniguchiHiroshi MoroHidetoshi IgariShigeru YoshidaTakanori TeshimaHideaki NakajimaMasako NishizawaYoshiyuki YokomakuYasumasa IwataniAtsuko HachiyaShingo KatoNaoki HasegawaKazuhisa YoshimuraWataru SugiuraTadashi KikuchiPublished in: The Journal of antimicrobial chemotherapy (2023)
The general guideline recommendation of second-generation INSTI-based first-line ART for most PLWH is also applicable to PLWH harbouring E157Q.
Keyphrases
- antiretroviral therapy
- hiv infected
- end stage renal disease
- human immunodeficiency virus
- hiv positive
- ejection fraction
- newly diagnosed
- hiv infected patients
- chronic kidney disease
- hiv aids
- clinical trial
- prognostic factors
- study protocol
- type diabetes
- hiv testing
- cross sectional
- patient reported outcomes
- south africa
- double blind
- skeletal muscle